$39.19
0.962.51%
Last update: Nov 5, 5:24 AM

The average analyst price target for Xenon Pharmaceuticals is $61.89, 58.7% above the current price. Of 18 analysts, 17 rate it Buy and 1 Hold. Targets range from $46 to $90. The latest change came on Oct 6, 2026, when Guggenheim assumed coverage of Xenon Pharmaceuticals with a Buy rating and a $73 price target.
Price Target Range — 13 Quarters
Analyst Consensus — 18 Analysts
Rating Trend — Last 9 Months